Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
863 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
21 Recruiting A Study of Intermittent, High-dose Afatinib to Determine the Maximal Tolerated Dose and Assess Activity of This Dose Against Non-small Cell Lung Cancer With T790M Mutations
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Dose escalation followed by treatment with MTD
22 Recruiting Chemotherapy Combined With Whole-body Hyperthermia to Treat Stage IIIB/IV Non Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer Stage IIIB;   Toxicity Due to Chemotherapy
Intervention: Device: chemotherapy & WBH
23 Recruiting Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
Conditions: Advanced Solid Tumors;   Colorectal Cancer;   Squamous Cell Head and Neck Cancer;   Non Small Cell Lung Cancer;   Triple Negative Breast Cancer
Interventions: Drug: MM-151;   Drug: MM-151 + irinotecan
24 Recruiting Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Radiation: Stereotactic Body Radiation Therapy (SBRT);   Drug: cisplatin or carboplatin-based
25 Not yet recruiting Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors
Conditions: Recurrent Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: buparlisib;   Drug: gemcitabine hydrochloride;   Drug: cisplatin;   Other: pharmacological study;   Other: laboratory biomarker analysis;   Other: questionnaire administration
26 Recruiting Erlotinib With or Without Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer With EGFR Mutations
Condition: Stage IV Non-small Cell Lung Cancer
Interventions: Drug: erlotinib;   Biological: bevacizumab;   Other: laboratory biomarker analysis
27 Unknown  Neoadjuvant Concurrent Chemoradiation With Weekly Docetaxel/Cisplatin for Resectable IIIA-N2 NSCLC
Condition: Non-small Cell Lung Cancer
Interventions: Drug: docetaxel/cisplatin;   Radiation: Radiation
28 Unknown  Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC
Condition: Stage III Non-small-Cell Lung Cancer
Intervention: Drug: Recombinant human endostatin
29 Recruiting Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors
Conditions: Breast Cancer;   Ovarian Cancer;   Gynecological Cancer;   Head and Neck Carcinoma;   Non-small Cell Lung Cancer;   Small Cell Lung Cancer;   Non-squamous Cell Lung Cancer
Intervention: Drug: PM01183 + paclitaxel +/- bevacizumab
30 Recruiting A Study Of Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: Dacomitinib
31 Unknown  Study of 3D Radiotherapy With or Without Erlotinib (Tarceva®) in Patients With Localized Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Erlotinib (Tarceva®)
32 Recruiting Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients
Conditions: Non Small-cell Lung Cancer;   Renal-cell Cancer;   Gastrointestinal Stroma Tumor
Interventions: Drug: Sunitinib;   Drug: Erlotinib;   Drug: Midazolam;   Drug: Caffeine
33 Not yet recruiting Pilot Study of SBRT Plus Chemotherapy for Non-small Cell Lung Carcinoma
Conditions: Stage I Non-Small Cell Lung Cancer;   Stage II Non-Small Cell Lung Cancer
Interventions: Radiation: Stereotactic Body Radiotherapy;   Drug: Carboplatin;   Drug: Paclitaxel Albumin-Stabilized Nanoparticle Formulation
34 Recruiting Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma
Condition: Lung Cancer, Small Cell
Intervention: Drug: GSK2879552
35 Unknown  Gefitinib or Docetaxel as Second Line Therapy for Wild-type Epidermal Growth Factor Receptor (EGFR) NSCLC
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Gefitinib;   Drug: Docetaxel
36 Recruiting A Global Study to Assess the Effects of MEDI4736 in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: MEDI4736
37 Recruiting Detect the Plasma Drug Concentration of Docetaxel and Paclitaxel, and Explore the Pharmacokinetically-guided Dosing Strategy
Conditions: Non-small Cell Lung Cancer;   Breast Cancer
Interventions: Device: Detection Kit;   Drug: PTX 175mg/m2, DOC 75mg/m2
38 Recruiting Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Lenalidomide
39 Recruiting SPECT/CT in Measuring Lung Function in Patients With Lung Cancer Undergoing Radiation Therapy
Conditions: Extensive Stage Small Cell Lung Cancer;   Limited Stage Small Cell Lung Cancer;   Occult Non-small Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer;   Stage IA Non-small Cell Lung Cancer;   Stage IB Non-small Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Radiation: technetium Tc 99m-labeled macroaggregated albumin;   Drug: technetium Tc 99m DTPA;   Procedure: single photon emission computed tomography;   Procedure: computed tomography;   Radiation: fludeoxyglucose F 18;   Procedure: positron emission tomography
40 Unknown  Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC)
Condition: Lung Neoplasms
Interventions: Drug: Treated by endostar combined with docetaxel and cisplatin;   Drug: Treated by docetaxel and cisplatin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years